Long-term effects of aluminium dust inhalation

Occup Environ Med. 2013 Dec;70(12):864-8. doi: 10.1136/oemed-2013-101487. Epub 2013 Oct 8.

Abstract

Objectives: During the 1950s and 1960s, aluminium dust inhalation was used as a potential prophylaxis against silicosis in underground miners, including in Australia. We investigated the association between aluminium dust inhalation and cardiovascular, cerebrovascular and Alzheimer's diseases in a cohort of Australian male underground gold miners. We additionally looked at pneumoconiosis mortality to estimate the effect of the aluminium therapy.

Methods: SMRs and 95% CI were calculated to compare mortality of the cohort members with that of the Western Australian male population (1961-2009). Internal comparisons on duration of aluminium dust inhalation were examined using Cox regression.

Results: Aluminium dust inhalation was reported for 647 out of 1894 underground gold miners. During 42 780 person-years of follow-up, 1577 deaths were observed. An indication of increased mortality of Alzheimer's disease among miners ever exposed to aluminium dust was found (SMR=1.38), although it was not statistically significant (95% CI 0.69 to 2.75). Rates for cardiovascular and cerebrovascular death were above population levels, but were similar for subjects with or without a history of aluminium dust inhalation. HRs suggested an increasing risk of cardiovascular disease with duration of aluminium dust inhalation (HR=1.02, 95% CI 1.00 to 1.04, per year of exposure). No difference in the association between duration of work underground and pneumoconiosis was observed between the groups with or without aluminium dust exposure.

Conclusions: No protective effect against silicosis was observed from aluminium dust inhalation. Conversely, exposure to aluminium dust may possibly increase the risk of cardiovascular disease and dementia of the Alzheimer's type.

MeSH terms

  • Administration, Inhalation
  • Aluminum / administration & dosage
  • Aluminum / adverse effects*
  • Alzheimer Disease / chemically induced*
  • Alzheimer Disease / mortality
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / mortality
  • Cerebrovascular Disorders / chemically induced
  • Cerebrovascular Disorders / mortality
  • Dust*
  • Follow-Up Studies
  • Gold
  • Humans
  • Male
  • Mining
  • Pneumoconiosis / etiology
  • Pneumoconiosis / mortality
  • Protective Agents / administration & dosage
  • Protective Agents / adverse effects*
  • Silicosis / mortality
  • Silicosis / prevention & control*
  • Western Australia / epidemiology

Substances

  • Dust
  • Protective Agents
  • Gold
  • Aluminum